- Key Topics
Management and Governance
- Sustainability Management
- Bayer Sustainability Council
- Stakeholder Dialogue
- UN Global Compact
- Group Regulations
- Protection of Biodiversity
- Modern Slavery Act Statement
- Position on Global Product Strategy
- Position on Responsible Care
- Bayer Water Position
- Position on Deforestation and Forest Degradation
- Postion on Insect Decline
- Raising the Bar on Crop Protection Safety Standards
- UN Sustainable Development Goals
- Codes of Conduct
- Development of Sustainability
- Supplier Management
- Human Rights
- Product Stewardship
- Environmental Protection
- Societal Engagement
- Ratings, Rankings and Awards
Partnerships for More Innovations
Bayer maintains a global network of research and development locations in which about 15,000 researchers around the world focus on improving the health of people, animals and plants. We augment our own research capacities through collaborations and strategic alliances with industrial and academic research partners around the world. These include leading universities, public research institutes, partner and start-up companies, and science and innovation centers established by Bayer to give young companies access to features such as suitable laboratory and office infrastructure in the direct vicinity of Bayer’s own research facilities.
These are supplemented by our crowdsourcing platforms through which researchers around the world can offer their expertise for collaboration with Bayer. With the newly established strategic innovation unit, the Bayer LifeScience Center (BLSC), we additionally want to drive the development of decisive interspecies research with the aid of a network of external partnerships. On the initiative of BLSC we signed an agreement at the end of 2015 with the biotech company CRISPR Therapeutics AG based in Basel, Switzerland, with the goal of discovering, developing and marketing new treatment methods for blood disorders, blindness and heart disease based on the CRISPR-Cas9 technology for gene editing.
“Partnerships at Pharmaceuticals”
Our understanding of biochemical processes and the underlying genetic causes of diseases is growing rapidly. Contemporary research and development require a level of specialization that one organization alone cannot achieve. With partnerships, we can leverage today’s scientific knowledge in its entirety and translate it into innovative medicines for patients.
We also work closely together with numerous partners in the area of social commitment.
Find out more about:
Food Chain Partnership
Food Chain Partnership is an innovative business model where farmers, food exporters and importers, processors and retailers work together on optimized crop solutions according to sustainable agricultural principles for the benefit of all partners involved. These benefits differ according to the key interests of our partners and range from enhancing product quality and increasing agricultural yields up to expanding marketing opportunities and improving traceability. However, the overall and common goal is the sustainable production of abundant and nutritious food. Currently, there are projects in 30 countries worldwide focusing on 40 different crops, such as fruits, vegetable, wheat and rice. In these collaborations, we offer our customers – according to their needs – a tailored crop solution consisting of high-quality seeds, effective crop protection, and expertise in environmental protection, efficiency and safety.
Public Private Partnership
We aim to contribute to increased agricultural productivity in regions such as Africa and Asia and intend to expand our presence there. Our offerings are tailored to the needs of those farmers and range from integrated crop solutions based on improved seed varieties through modern crop protection technologies and training in good agricultural practice and environmental protection to product safety programs. We also engage locally in Public-Private Partnerships (PPPs) to help increase the income of smallholder farmers through sustainable agriculture. Activities include expanding local value chains and training measures. This contributes to improving the living situation of the local population and enhancing the availability of staple foods, fruits and vegetables in the project countries. In such PPPs, we cooperate with numerous partners including local governments, farmers’ associations and cooperatives, nongovernmental organizations and agricultural input industries. We are currently participating in PPPs associated with the value chains for rice and potatoes in Sub-Saharan Africa, India and Southeast Asia.
Boosting productivity of the agricultural sector in emerging and developing countries requires close collaboration between government and the private sector. In Germany, the Federal Ministry for Economic Cooperation and Development in June 2012 put together an initiative on food security in emerging and developing companies. We are a founding member and the initiative will - in the words of Liam Condon, Member of the Board of Management of Bayer AG and President of the Crop Science Division - ‘make a sustainable contribution to strengthening food security for our hungry planet.' Specifically, it harnesses the expertise of companies to address the agricultural productivity gap in emerging and developing countries. Local food value chains are strengthened, with supply chains made more efficient and sustainable. This is how we stabilize food production and availability for the people who need it the most.